217 related articles for article (PubMed ID: 23873098)
1. Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma.
Yan L; Li S; Xu C; Zhao X; Hao B; Li H; Qiao B
Tumour Biol; 2013 Dec; 34(6):4089-100. PubMed ID: 23873098
[TBL] [Abstract][Full Text] [Related]
2. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.
Yan L; Li Q; Yang J; Qiao B
J Cell Biochem; 2018 Feb; 119(2):1791-1803. PubMed ID: 28799673
[TBL] [Abstract][Full Text] [Related]
3. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y
Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064
[TBL] [Abstract][Full Text] [Related]
4. TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
Yang X; Liu G; Xiao H; Yu F; Xiang X; Lu Y; Li W; Liu X; Li S; Shi Y
Pathol Oncol Res; 2014 Jul; 20(3):641-8. PubMed ID: 24488334
[TBL] [Abstract][Full Text] [Related]
5. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
Liang B; Jia C; Huang Y; He H; Li J; Liao H; Liu X; Liu X; Bai X; Yang D
Dig Dis Sci; 2015 Aug; 60(8):2360-72. PubMed ID: 26025609
[TBL] [Abstract][Full Text] [Related]
6. TPX2 promotes cell proliferation and migration via PLK1 in OC.
Ma S; Rong X; Gao F; Yang Y; Wei L
Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
[TBL] [Abstract][Full Text] [Related]
7. The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer.
Chang H; Wang J; Tian Y; Xu J; Gou X; Cheng J
Oncol Rep; 2012 May; 27(5):1353-9. PubMed ID: 22307108
[TBL] [Abstract][Full Text] [Related]
8. Expression of targeting protein for Xenopus kinesin-like protein 2 is associated with progression of human malignant astrocytoma.
Li B; Qi XQ; Chen X; Huang X; Liu GY; Chen HR; Huang CG; Luo C; Lu YC
Brain Res; 2010 Sep; 1352():200-7. PubMed ID: 20599806
[TBL] [Abstract][Full Text] [Related]
9. TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide.
Zhang L; Huang H; Deng L; Chu M; Xu L; Fu J; Zhu Y; Zhang X; Liu S; Zhou Z; Wang Y
Toxicology; 2008 Oct; 252(1-3):49-55. PubMed ID: 18723071
[TBL] [Abstract][Full Text] [Related]
10. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
11. TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT.
Zou Z; Zheng B; Li J; Lv X; Zhang H; Yu F; Kong L; Li Y; Yu M; Fang L; Liang B
Biomed Pharmacother; 2018 Nov; 107():1286-1293. PubMed ID: 30257343
[TBL] [Abstract][Full Text] [Related]
12. Targeting protein for xenopus kinesin-like protein 2 (TPX2) regulates γ-histone 2AX (γ-H2AX) levels upon ionizing radiation.
Neumayer G; Helfricht A; Shim SY; Le HT; Lundin C; Belzil C; Chansard M; Yu Y; Lees-Miller SP; Gruss OJ; van Attikum H; Helleday T; Nguyen MD
J Biol Chem; 2012 Dec; 287(50):42206-22. PubMed ID: 23045526
[TBL] [Abstract][Full Text] [Related]
13. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.
Liang B; Zheng W; Fang L; Wu L; Zhou F; Yin X; Yu X; Zou Z
Cancer Biol Ther; 2016 Aug; 17(8):824-32. PubMed ID: 27314162
[TBL] [Abstract][Full Text] [Related]
15. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
16. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
17. [TPX2 expression and its significance in squamous cell carcinoma of lung].
Lin DM; Ma Y; Xiao T; Guo SP; Han NJ; Su K; Yi SZ; Fang J; Cheng SJ; Gao YN
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):540-4. PubMed ID: 17134548
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
19. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.
Wei P; Zhang N; Xu Y; Li X; Shi D; Wang Y; Li D; Cai S
J Transl Med; 2013 Dec; 11():313. PubMed ID: 24341487
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.
Miwa T; Kokuryo T; Yokoyama Y; Yamaguchi J; Nagino M
Cancer Med; 2015 Jul; 4(7):1091-100. PubMed ID: 25914189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
